122 related articles for article (PubMed ID: 33906292)
61. Receptor Tyrosine Kinase EphB3: a Prognostic Indicator in Colorectal Carcinoma.
Xuan Z; Huang J; Gao L; Wang Y; Wang J; Sun Y
Pathol Oncol Res; 2020 Jan; 26(1):541-549. PubMed ID: 30535864
[TBL] [Abstract][Full Text] [Related]
62. PYGO2 as an independent diagnostic marker expressed in a majority of colorectal cancers.
Soleymani S; Khales SA; Jafarian AH; Kalat HR; Forghanifard MM
J Histotechnol; 2019 Sep; 42(3):98-103. PubMed ID: 31492088
[TBL] [Abstract][Full Text] [Related]
63. Downregulation of phosphorylated MKK4 is associated with a poor prognosis in colorectal cancer patients.
Wang PN; Huang J; Duan YH; Zhou JM; Huang PZ; Fan XJ; Huang Y; Wang L; Liu HL; Wang JP; Huang MJ
Oncotarget; 2017 May; 8(21):34352-34361. PubMed ID: 28423721
[TBL] [Abstract][Full Text] [Related]
64. Implications of CEA and p53 overexpression in the poor prognosis of colorectal cancer.
Nasif WA; Lotfy M; El-Sayed IH; El-Kenawy Ael-M; El-Shahat M; El-Hak NG
Med Oncol; 2006; 23(2):237-44. PubMed ID: 16720924
[TBL] [Abstract][Full Text] [Related]
65. [Expression of microRNA-152 in colorectal cancer and its relationship with prognosis].
Wang Y; Yuan W; Ma X; Ma J
Zhonghua Zhong Liu Za Zhi; 2016 Oct; 38(10):763-766. PubMed ID: 27784461
[No Abstract] [Full Text] [Related]
66. Mesenchymal marker and LGR5 expression levels in circulating tumor cells correlate with colorectal cancer prognosis.
Wang W; Wan L; Wu S; Yang J; Zhou Y; Liu F; Wu Z; Cheng Y
Cell Oncol (Dordr); 2018 Oct; 41(5):495-504. PubMed ID: 29949050
[TBL] [Abstract][Full Text] [Related]
67. SATB1 Expression of Colorectal Adenomatous Polyps is Higher than that of Colorectal Carcinomas.
Yalcin GS; Gonultas MA; Hucumenoglu S; Simsek G; Pekcici MR
Appl Immunohistochem Mol Morphol; 2020 Aug; 28(7):532-537. PubMed ID: 31290787
[TBL] [Abstract][Full Text] [Related]
68. Low expression of chloride channel accessory 1 predicts a poor prognosis in colorectal cancer.
Yang B; Cao L; Liu J; Xu Y; Milne G; Chan W; Heys SD; McCaig CD; Pu J
Cancer; 2015 May; 121(10):1570-80. PubMed ID: 25603912
[TBL] [Abstract][Full Text] [Related]
69. Decreased expression of PinX1 protein predicts poor prognosis of colorectal cancer patients receiving 5-FU adjuvant chemotherapy.
Deng W; Jiao N; Li N; Wan X; Luo S; Zhang Y
Biomed Pharmacother; 2015 Jul; 73():1-5. PubMed ID: 26211574
[TBL] [Abstract][Full Text] [Related]
70. High expression of PFTK1 in cancer cells predicts poor prognosis in colorectal cancer.
Mao Y; Jia Y; Zhu H; Wang W; Jin Q; Huang F; Zhang S; Li X
Mol Med Rep; 2017 Jul; 16(1):224-230. PubMed ID: 28498444
[TBL] [Abstract][Full Text] [Related]
71. Relationships among
Wan XB; Wang AQ; Cao J; Dong ZC; Li N; Yang S; Sun MM; Li Z; Luo SX
World J Gastroenterol; 2019 Feb; 25(7):808-823. PubMed ID: 30809081
[TBL] [Abstract][Full Text] [Related]
72. Cutoff of 25% for Ki67 expression is a good classification tool for prognosis in colorectal cancer in the AJCC‑8 stratification.
Tong G; Zhang G; Liu J; Zheng Z; Chen Y; Niu P; Xu X
Oncol Rep; 2020 Apr; 43(4):1187-1198. PubMed ID: 32323802
[TBL] [Abstract][Full Text] [Related]
73. The relationship between overexpression of glial cell-derived neurotrophic factor and its RET receptor with progression and prognosis of human pancreatic cancer.
Zeng Q; Cheng Y; Zhu Q; Yu Z; Wu X; Huang K; Zhou M; Han S; Zhang Q
J Int Med Res; 2008; 36(4):656-64. PubMed ID: 18652760
[TBL] [Abstract][Full Text] [Related]
74. Upregulated CNTN1 is associated with lymph node metastasis and poor prognosis of colorectal cancer.
Li G; Zhang Z; Ge G; Fang K; Zhu J
Cancer Biomark; 2021; 30(2):193-201. PubMed ID: 33104020
[TBL] [Abstract][Full Text] [Related]
75. Clinicopathological significance of PD-L1 expression in colorectal cancer: Impact of PD-L1 expression on pFOXO1 expression.
Pyo JS; Ko SH; Ko YS; Kim NY
Pathol Res Pract; 2020 Feb; 216(2):152764. PubMed ID: 31836325
[TBL] [Abstract][Full Text] [Related]
76. Overexpression of NDUFA4L2 is associated with poor prognosis in patients with colorectal cancer.
Lv Y; Nie SL; Zhou JM; Liu F; Hu YB; Jiang JR; Li N; Liu JS
ANZ J Surg; 2017 Dec; 87(12):E251-E255. PubMed ID: 27226356
[TBL] [Abstract][Full Text] [Related]
77. Maspin is a marker for early recurrence in primary stage III and IV colorectal cancer.
Snoeren N; Emmink BL; Koerkamp MJ; van Hooff SR; Goos JA; van Houdt WJ; de Wit M; Prins AM; Piersma SR; Pham TV; Belt EJ; Bril H; Stockmann HB; Meijer GA; van Hillegersberg R; Holstege FC; Jimenez CR; Fijneman RJ; Kranenburg OW; Rinkes IH
Br J Cancer; 2013 Sep; 109(6):1636-47. PubMed ID: 24002600
[TBL] [Abstract][Full Text] [Related]
78. Unmasking a new prognostic marker and therapeutic target from the GDNF-RET/PIT1/p14ARF/p53 pathway in acromegaly.
Chenlo M; Rodriguez-Gomez IA; Serramito R; Garcia-Rendueles AR; Villar-Taibo R; Fernandez-Rodriguez E; Perez-Romero S; Suarez-Fariña M; Garcia-Allut A; Cabezas-Agricola JM; Rodriguez-Garcia J; Lear PV; Alvarez-San Martin RM; Alvarez-Escola C; Bernabeu I; Alvarez CV
EBioMedicine; 2019 May; 43():537-552. PubMed ID: 30975543
[TBL] [Abstract][Full Text] [Related]
79. Reduced expression of SM22 is correlated with low autophagy activity in human colorectal cancer.
Xie XL; Liu YB; Liu YP; Du BL; Li Y; Han M; Li BH
Pathol Res Pract; 2013 Apr; 209(4):237-43. PubMed ID: 23538046
[TBL] [Abstract][Full Text] [Related]
80. Annexin A13 promotes tumor cell invasion in vitro and is associated with metastasis in human colorectal cancer.
Jiang G; Wang P; Wang W; Li W; Dai L; Chen K
Oncotarget; 2017 Mar; 8(13):21663-21673. PubMed ID: 28423508
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
